Vanguard Group’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
PMG
KBG
SCM
Vanguard Group's OGN Position: Q4 2025 in Review
Vanguard Group increased its Organon & Co (OGN) stake by 2.7% in Q4 2025, buying an estimated $7.81M and bringing the position to 36,916,382 shares worth $265M. The position accounts for ﹤0.01% of the portfolio, ranked #1398.
Vanguard Group first reported a position in OGN in Q2 2021 and has held it in 19 quarters since. The position peaked at $1.02B in Q1 2022. 634 funds tracked by Wall St. Rank hold OGN as of Q4 2025.
- Vanguard Group held 36,916,382 shares of Organon & Co worth $265M as of Q4 2025.
- Vanguard Group bought 987,979 Organon & Co shares in Q4 2025, an estimated $7.81M.
- Organon & Co made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #1398 holding.
- Vanguard Group first reported a position in Organon & Co in Q2 2021 and has held it in 19 quarters since.
- Vanguard Group's Organon & Co position peaked at $1.02B in Q1 2022.
- 634 funds tracked by Wall St. Rank held Organon & Co as of Q4 2025.
Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.